2017HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
2017HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
复制标题
DOI：
10.1016/j.joa.2017.08.001
复制
发表时间：
2017-10-01
影响因子：
2
通讯作者：
Yamane, Teiichi
中科院分区：
文献类型：
--
作者：
Calkins, Hugh;Hindricks, Gerhard;Yamane, Teiichi
在过去的三十年里，导管和手术消融房颤(AF)已经从研究程序发展到目前作为房颤患者有效治疗选择的作用。房颤的外科消融，使用标准的、微创的或混合的技术，在世界上大多数主要医院都可以使用。房颤的导管消融更加广泛，现在是最常见的导管消融程序。2007年，作为心脏节律学会(HRS)、欧洲心脏节律协会(EHRA)和欧洲心律失常学会(ECAS)的共同努力，初步达成了关于导管和外科房颤消融的共识声明[1]。2007年的文件也是与胸科外科医生学会(STS)和美国心脏病学会(ACC)合作开发的。这份关于导管和外科房颤消融的共识声明于2012年重写，以反映在此期间房颤消融取得的许多进展[2]。随着巨大的研究努力集中在房颤的机制、结果和治疗上，房颤消融的工具、技术和结果的进步速度继续增加。出于这个原因，人力资源管理局开始努力重写和更新这一共识声明。这份文件既反映了房颤的全球重要性，也反映了房颤消融的全球性能，是HRS、EHRA、ECAS、亚太心脏节律协会(APHRS)和拉丁美洲心脏刺激和电生理学会(Society edad Latinoamericana de Eacomación Cardíaca y Electrfisiología[SOLAECA])共同合作的结果。这份2017年共识声明的目的是对房颤导管和外科消融领域进行最先进的审查，并报告由这五个国际学会召集的写作小组的调查结果。撰写小组负责定义房颤消融程序的适应症、技术和结果。本文件包括与房颤消融领域的临床试验设计和结果报告相关的建议，包括与该主题相关的定义。编写小组由代表11个组织的60名专家组成：HRS、EHRA、ECAS、APHRS、SOLACES、STS、ACC、美国心脏协会(AHA)、加拿大心脏节律协会(CHRS)、日本心脏节律协会(JHRS)和巴西心律失常学会(巴西心脏节律协会[SOBRAC])。全
During the past three decades, catheter and surgical ablation of atrial fibrillation (AF) have evolved from investigational procedures to their current role as effective treatment options for patients with AF. Surgical ablation of AF, using either standard, minimally invasive, or hybrid techniques, is available in most major hospitals throughout the world. Catheter ablation of AF is even more widely available, and is now the most commonly performed catheter ablation procedure. In 2007, an initial Consensus Statement on Catheter and Surgical AF Ablation was developed as a joint effort of the Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA), and the European Cardiac Arrhythmia Society (ECAS)[1]. The 2007 document was also developed in collaboration with the Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC). This Consensus Statement on Catheter and Surgical AF Ablation was rewritten in 2012 to reflect the many advances in AF ablation that had occurred in the interim [2]. The rate of advancement in the tools, techniques, and outcomes of AF ablation continue to increase as enormous research efforts are focused on the mechanisms, outcomes, and treatment of AF. For this reason, the HRS initiated an effort to rewrite and update this Consensus Statement. Reflecting both the worldwide importance of AF, as well as the worldwide performance of AF ablation, this document is the result of a joint partnership between the HRS, EHRA, ECAS, the Asia Pacific Heart Rhythm Society (APHRS), and the Latin American Society of Cardiac Stimulation and Electrophysiology (Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología [SOLAECE]). The purpose of this 2017 Consensus Statement is to provide a state-of-the-art review of the field of catheter and surgical ablation of AF and to report the findings of a writing group, convened by these five international societies. The writing group is charged with defining the indications, techniques, and outcomes of AF ablation procedures. Included within this document are recommendations pertinent to the design of clinical trials in the field of AF ablation and the reporting of outcomes, including definitions relevant to this topic. The writing group is composed of 60 experts representing 11 organizations: HRS, EHRA, ECAS, APHRS, SOLAECE, STS, ACC, American Heart Association (AHA), Canadian Heart Rhythm Society (CHRS), Japanese Heart Rhythm Society (JHRS), and Brazilian Society of Cardiac Arrhythmias (Sociedade Brasileira de Arritmias Cardíacas [SOBRAC]). All